<div id='accordion'>
    <div class="card timetable-card timetable__card-panel timetable_lightPink" data-toggle='collapse' data-target='#collapseNewApp' aria-expanded="true" aria-controls="collapseNewApp">
        <div class="card-body">
            <h5 class="card-title">13:30</h5>
            <h6 class="card-subtitle mb-2 text-muted">Room Commandants</h6>
            <p class="card-text"><b>New Approaches to Parkinsonâ€™s & Other Movement Disorders Panel</b></p>
        </div>
    </div>
    <div id="collapseNewApp" class="collapse" aria-labelledby="headingOne" data-parent="#accordion">
        <div class="card-body">
            <p class='timetable__text-italic'>Co-Chaired by:</p>

            <p><b>
                <a href='/speakers/22' class='timetable__modal-button'> Isaac Veinbergs, </a>
            </b>VP, Corporate Development, <b>ACADIA Pharmaceuticals, Inc.</b></p>

            <p><b>
                <a href='/speakers/45' class='timetable__modal-button'> Murali Gopalakrishnan, </a>
            </b>Sr. Director, Head of Search & Evaluation - Neuroscience, Corporate Strategy Office, <b>AbbVie, Inc.</b></p>

            <p class='timetable__text-italic'>Panelists:</p>

            <p><b>
                <a href='/speakers/11' class='timetable__modal-button'> Charles Stacey, </a>
            </b>President & CEO, <b>Cerecin Inc.</b></p>

            <p><b>
                <a href='/speakers/29' class='timetable__modal-button'> John Renger, </a>
            </b>CSO, <b>Cerevel Therapeutics, LLC</b></p>

            <p><b>
                <a href='/speakers/32' class='timetable__modal-button'> Ken Rhodes, </a>
            </b>CSO, <b>Yumanity Therapeutics</b></p>

            <p><b>
                <a href='/speakers/40' class='timetable__modal-button'> Marco Baptista, </a>
            </b>Director of Research Programs, <b>The Michael J. Fox Foundation for Parkinson's Research</b></p>

            <p><b>
                <a href='/speakers/47' class='timetable__modal-button'> Nicholas Hertz, </a>
            </b>CSO, <b>Mitokinin, Inc.</b></p>

        </div>
    </div>
</div>